JENNI WADE: Open Payments
NPI 1821473885 · THOMASVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,227 in 65 payments from 10 companies in 2025. Trend: 2023 $609 · 2024 $883 · 2025 $1,227
Food & beverage: $1,227
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $257 |
| Merck Sharp & Dohme LLC | 11 | $218 |
| Novartis Pharmaceuticals Corporation | 8 | $172 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $147 |
| BridgeBio Pharma, Inc. | 7 | $132 |
| PFIZER INC. | 6 | $117 |
| Amgen Inc. | 4 | $61 |
| E.R. Squibb & Sons, L.L.C. | 3 | $52 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $50 |
| Kestra Medical Technology Services, Inc. | 1 | $21 |
Products named: VERQUVO, FARXIGA, LEQVIO, JARDIANCE, Attruby, ELIQUIS, REPATHA, CAMZYOS.
Industry payments across GA — which companies pay providers there.
